✦ LIBER ✦

Imatinib Maintenance Following Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Philadelphia Chromosome Positive (PH+) Acute Lymphoblastic Leukemia (ALL)

✍ Scribed by P. Kebriaei; A. Chiattone; R. Saliba; D. Jones; P. Anderlini; B. Andersson; I. Khouri; L. Worth; F. Ravandi; D. Thomas; H. Kantarjian; N. Hamerschlak; M. Rodrigues; M. de Lima; S. Giralt; R. Champlin

Book ID: 116281438
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 54 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintenance therapy with dasatinib after

Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Teng, Chieh-Lin Jerry; Yu, Jui-Ting; Chen, Hung-Chieh; Hwang, Wen-Li 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 92 KB

149: Allogeneic Hematopoietic Cell Trans

149: Allogeneic Hematopoietic Cell Transplantation (allo-HCT) for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemias: Impact of Imatinib on Risk of Relapse and Survival

✍ M.J. Burke; B. Trotz; X. Luo; T.E. DeFor; L.J. Burns; K.S. Baker; D.J. Weisdorf; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Dasatinib followed by second allogeneic

Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation

✍ Yoko Ishida; Kiriko Terasako; Kumi Oshima; Kana Sakamoto; Masahiro Ashizawa; Mik 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 328 KB

Therapy with imatinib mesylate (Glivec)

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

✍ Gschaidmeier, H; Hoelzer, D; Ottmann, O G; Wassmann, B; Pfeifer, H; Scheuring, U 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

Clinical Outcome of Hematopoietic Stem C

Clinical Outcome of Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL): Experience From a Single Institution

✍ Noriko Doki, Kazuteru Ohashi, Gaku Oshikawa… 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 338 KB

Imatinib compared with chemotherapy as f

Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)

✍ Oliver G. Ottmann; Barbara Wassmann; Heike Pfeifer; Aristoteles Giagounidis; Mat 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

## Abstract ## BACKGROUND Elderly patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ALL) have a poor prognosis, with a low complete remission (CR) rate, high induction mortality, and short remission duration. Imatinib (IM) has a favorable toxicity profile but limited